$14.63
3.6733.49%
At close: -
$14.70
0.070.47%
After Hours: 7:59 PM EDT
Tonix Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Tonix Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $-23.00 | $-293.00 | 92.2 % |
Q2 | 2024-08-16 | $-1.93K | $-720.00 | -167.8 % |
Q1 | 2024-05-13 | $-576.00 | $-1.25K | 53.8 % |
Q4 | 2024-04-01 | $-2.75K | $-5.25K | 47.6 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $2.82M | $3.08M | -8.38 % |
Q2 | 2024-08-16 | $2.21M | $3.35M | -34.1 % |
Q1 | 2024-05-13 | $2.48M | $3.80M | -34.7 % |
Q4 | 2024-04-01 | $3.78M | $3.83M | -1.33 % |
Tonix Pharmaceuticals (TNXP) is scheduled to report earnings on May 12, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-23.00, which beat the estimate of $-293.00.
The Actual Revenue was $2.8M, which missed the estimate of $3.1M.
Browse earnings estimates, EPS, and revenue on all stocks.